Antitumor activity of the combination of an HSP90 inhibitor and a PI3K/mTOR dual inhibitor against cholangiocarcinoma.
Chen MH, Chiang KC, Cheng CT, Huang SC, Chen YY, Chen TW, Yeh TS, Jan YY, Wang HM, Weng JJ, Chang PM, Liu CY, Li CP, Chao Y, Chen MH, Huang CY, Yeh CN.
Chen MH, et al. Among authors: huang sc, huang cy.
Oncotarget. 2014 May 15;5(9):2372-89. doi: 10.18632/oncotarget.1706.
Oncotarget. 2014.
PMID: 24796583
Free PMC article.